GT Biopharma Inc. (GTBP) PT Lowered to $18 at B.Riley
Get Alerts GTBP Hot Sheet
Price: $0.29 -3.33%
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
B.Riley analyst Chad Mabry lowered the price target on GT Biopharma Inc. (NASDAQ: GTBP) to $18.00 (from $26.00) while maintaining a Buy rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- E Ink Holdings Inc (8069:TT) PT Lowered to NT$200 at Macquarie
- Rakus Co Ltd (3923:JP) PT Raised to JPY1,300 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share